The Technical Analyst
CareMax, Inc. [CMAX]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
CareMax, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-4.38% $2.40
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 9.13 mill |
| EPS: | -183.29 |
| P/E: | -0.0100 |
| Earnings Date: | May 07, 2024 |
| SharesOutstanding: | 3.80 mill |
| Avg Daily Volume: | 0.0900 mill |
| RATING 2024-04-18 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0100 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.0100 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.908 - 3.89 ( +/- 62.17%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-11-17 | Flynn James E | Buy | 12 123 | Class A Common Stock |
| 2023-11-17 | Flynn James E | Sell | 12 123 | Restricted Stock Units |
| 2023-11-17 | Berg Kevin | Buy | 12 123 | Class A Common Stock |
| 2023-11-17 | Berg Kevin | Sell | 12 123 | Restricted Stock Units |
| 2023-11-17 | De La Torre Ralph | Buy | 10 927 | Class A Common Stock |
| INSIDER POWER |
|---|
| 69.38 |
| Last 95 transactions |
| Buy: 2 159 229 | Sell: 13 709 257 |
Forecast:
16:00 - $2.35
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $2.35
Forecast 2: 16:00 - $2.35
Forecast 3: 16:00 - $2.35
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.40 (-4.38% ) |
| Volume | 0.0577 mill |
| Avg. Vol. | 0.0900 mill |
| % of Avg. Vol | 64.13 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CMAX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CMAX
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
Latest Press Releases
2024-03-18 06:55:00 - Press Release
Caremax Reports Fourth Quarter And Full Year 2023 Results
Miami--(business wire)--caremax, inc. (nasdaq: cmax; cmaxw) (“caremax” or the “company”), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended december 31, 2023. “in the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business,” said carlos de solo, chief executive officer. “we have made difficult but necessary decisions to de-emphasize certain longer du.
2024-03-12 14:50:00 - Press Release
Cmax Alert: Levi & Korsinsky, Llp Commences An Investigation Of Caremax, Inc. (cmax) F/k/a Deerfield Healthcare Technology Acquisitions Corp. (dfht)
New york , march 12, 2024 /prnewswire/ -- the following statement is being issued by levi & korsinsky, llp:1 to: all persons or entities who purchased caremax, inc. ("(cmax) " or the "company") ( nasdaq: cmax ) stock prior to may 25, 2021 levi & korsinsky, llp has commenced an investigation into potential breaches of fiduciary duty by the cmax board of directors. to learn more about the action and your rights, go to: https://zlk.com/mna2/caremax-inc-lawsuit-submission-form or contact joseph e.
2024-01-29 17:00:00 - Press Release
Caremax Announces 1-for-30 Reverse Stock Split
Miami--(business wire)--caremax, inc. (nasdaq: cmax; cmaxw) (“caremax” or the “company”), a leading technology-enabled value-based care delivery system, today announced that the company's board of directors (the “board”) has approved a 1-for-30 reverse stock split (the “reverse stock split”) of its class a common stock, par value $0.0001 per share (the “class a common stock”), that is expected to become effective on wednesday, january 31, 2024 at 11:59 p.m. eastern time (the “effective time”).
2023-11-09 06:55:00 - Press Release
Caremax Reports Third Quarter 2023 Results
Miami--(business wire)--caremax, inc. (nasdaq: cmax; cmaxw) (“caremax” or the “company”), a leading technology-enabled value-based care delivery system, today announced financial results for the third quarter ended september 30, 2023. “tomorrow marks one year since the acquisition of our national mso and nearly two and a half years of rapid growth in our patient and provider base. over that period, we experienced fluctuations in our revenue and ebitda as we underwent numerous initiatives to int.
2023-10-25 06:55:00 - Press Release
Caremax Schedules Third Quarter 2023 Earnings Conference Call
Miami--(business wire)--caremax, inc. (“caremax”) (nasdaq: cmax; cmaxw), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on thursday, november 9, 2023, and host a conference call at 8:30 am eastern time the same day to discuss the results. the conference call can be accessed by dialing (888) 330-2508 for u.s. participants, or (240) 789-2735 for international participants.
Latest News
2024-04-07 12:33:49 - InvestorPlace
3 Stocks That Are Actually Worth Shorting for Endless Gains
There's an old Wall Street adage that says “the market can stay irrational longer than you can stay solvent.” We saw that play out time and again with certain beaten-down stocks.
2024-04-01 07:26:14 - Zacks Investment Research
New Strong Sell Stocks for April 1st
BMRC, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2023.
2024-03-28 06:10:12 - Zacks Investment Research
New Strong Sell Stocks for March 28th
ASLE, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2023.
2024-03-20 07:31:16 - Zacks Investment Research
New Strong Sell Stocks for March 20th
CMAX, LNZA and HSON have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2024.
2023-11-11 07:42:08 - Seeking Alpha
CareMax, Inc. (CMAX) Q3 2023 Earnings Call Transcript
CareMax, Inc. (NASDAQ:CMAX ) Q3 2023 Earnings Conference Call November 9, 2023 8:30 AM ET Company Participants Roger Ou - Senior Vice President of Investor Relations Carlos de Solo - Co-Founder, President, CEO & Director Kevin Wirges - EVP, CFO & Treasurer Conference Call Participants Eduardo Ron - Truist Securities Jessica Tassan - Piper Sandler Jack Slevin - Jefferies Operator Good morning, and welcome to the CareMax, Inc. Third Quarter 2023 Financial Results and Conference Call. [Operator Instructions] I would now like to turn today's call over to Roger Ou, Senior Vice President of Investor Relations.
2023-10-25 06:55:00 - Business Wire
CareMax Schedules Third Quarter 2023 Earnings Conference Call
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants.
2023-10-10 16:46:21 - Seeking Alpha
CareMax Strategy Faces High Initial MER Costs
CareMax, Inc. provides value-based care services to seniors in the United States. The firm's strategy is to elect into full-risk MSO Medicare plans even though it may have higher initial expense ratios. With tight liquidity, cash burn and heavy upfront MER costs, I'm Neutral [Hold] on CareMax, Inc. shares for now.
2023-09-06 06:55:00 - Business Wire
CareMax to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer, Carlos de Solo, and Chief Financial Officer, Kevin Wirges, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023, at 7:30 am Eastern Time. A live webcast and replay of the event will be available on CareMax's investor relations webs.
2023-08-09 09:58:17 - Zacks Investment Research
CareMax, Inc. (CMAX) Reports Q2 Loss, Tops Revenue Estimates
CareMax, Inc. (CMAX) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.11 per share a year ago.
2023-07-19 06:55:00 - Business Wire
CareMax Schedules Second Quarter 2023 Earnings Conference Call
MIAMI--(BUSINESS WIRE)--CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that it will release its financial results for the second quarter 2023 before the opening of the financial markets on Wednesday, August 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for.